Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-center, Two-arm, Open-label, Externally Controlled, Post-marketing Study of the Effectiveness and Safety of Vericiguat in HFrEF Patients in China

NCT05728502 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT05728502
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05728502 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-center, Two-arm, Open-label, Externally Controlled, Post-marketing Study of the Effectiveness and Safety of Vericiguat in HFrEF Patients in China
Lead sponsor
Bayer
Phase
Observational
Overall status
Completed
Start date
April 25, 2023
Completion date
December 26, 2025
Enrollment
2,400 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic heart failure with reduced ejection fraction